Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Clinical Trials
1.5k
Active:27
Completed:804
Trial Phases
5 Phases
Phase 1:32
Phase 2:124
Phase 3:35
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1129 trials with phase data)• Click on a phase to view related trials
Not Applicable
760 (67.3%)Phase 4
178 (15.8%)Phase 2
124 (11.0%)Phase 3
35 (3.1%)Phase 1
32 (2.8%)EXPORT Randomized Trial
Not Applicable
Not yet recruiting
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 406
- Registration Number
- NCT07197931
- Locations
- 🇰🇷
Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
Active, not recruiting
- Conditions
- Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
- Interventions
- Drug: SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin)Drug: DPP4 inhibitors
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200000
- Registration Number
- NCT07198191
- Locations
- 🇰🇷
Yongin Severance Hospital, Yonsei University Health System, Yongin, Gyeonggi-do, South Korea
A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF
Not Applicable
Not yet recruiting
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2025-09-15
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 1230
- Registration Number
- NCT07173673
- Locations
- 🇰🇷
Yonsei University College of Medicine, Seoul, South Korea
Efficacy & Safety of hADM Skin Booster
Not Applicable
Completed
- Conditions
- RhytidesSkin Texture IrregularitiesPhotoaged Facial SkinSkin Lifting and Tightening
- Interventions
- Drug: Elravie Re2ODrug: Elravie Balance
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 20
- Registration Number
- NCT07155278
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
Effectiveness and Safety of Electrically Powered Orthopedic Exercise Device for Gait Disorders
Not Applicable
Recruiting
- Conditions
- Gait Disorders
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT07147543
- Locations
- 🇰🇷
Yongin Severance Hospital, Yongin-si, Gyeonggi-do, South Korea, South Korea
- Prev
- 1
- 2
- 3
- 4
- 5
- 268
- Next
News
No news found